Загрузка...
Direct oral anticoagulant drug level testing in clinical practice: a single institution experience
We performed a review of all direct oral anticoagulant (DOAC) levels – ecarin times for dabigatran and anti-Xa levels for rivaroxaban and apixaban – ordered at our institution with the purpose of evaluating DOAC levels from “real-world” (non-clinical trial) patients taking DOACs long-term, in order...
Сохранить в:
| Опубликовано в: : | Thromb Res |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4920718/ https://ncbi.nlm.nih.gov/pubmed/27179131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.thromres.2016.04.019 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|